Comment on ‘Costs of managing adverse events in the treatment of first-line metastatic renal cell carcinoma: bevacizumab in combination with interferon-α2a compared with sunitinib’...

Yazar: Charbonneau, C, Sandin, R
Baskı/Yayın Bilgisi 2010

Standardization of the Methylene Blue Reduction Test by the Use of Methylene Blue Thiocyanate

Yazar: Thornton, H. R., Sandin, R. B.
Baskı/Yayın Bilgisi 1935

Evidence for mannose-mediated adherence of Candida albicans to human buccal cells in vitro.

Yazar: Sandin, R L, Rogers, A L, Patterson, R J, Beneke, E S
Baskı/Yayın Bilgisi 1982

Comparison of the Vitek Immunodiagnostic Assay System with an indirect immunoassay (Toxostat Test Kit) for detection of immunoglobulin G antibodies to Toxoplasma gondii in clinical...

Yazar: Sandin, R L, Knapp, C C, Hall, G S, Washington, J A, Rutherford, I
Baskı/Yayın Bilgisi 1991

One disulfide bond in front of the second heavy chain constant region is necessary and sufficient for effector functions of human IgG3 without a genetic hinge.

Yazar: Michaelsen, T E, Brekke, O H, Aase, A, Sandin, R H, Bremnes, B, Sandlie, I
Baskı/Yayın Bilgisi 1994

Treatment and overall survival in renal cell carcinoma: a Swedish population-based study (2000–2008)

Yazar: Wahlgren, T, Harmenberg, U, Sandström, P, Lundstam, S, Kowalski, J, Jakobsson, M, Sandin, R, Ljungberg, B
Baskı/Yayın Bilgisi 2013

Overall survival in renal cell carcinoma after introduction of targeted therapies: a Norwegian population-based study

Yazar: Beisland C, Johannesen TB, Klepp O, Axcrona U, Torgersen KM, Kowalski J, Solli O, Sandin R, Oldenburg J
Baskı/Yayın Bilgisi 2017-01-01